Skip to main content
Erschienen in: Journal of Clinical Immunology 7/2014

01.10.2014 | Original Research

Helios Expression in T-regulatory Cells in Patients with di George Syndrome

verfasst von: Adam Klocperk, Jarmila Grecová, Kristýna Šišmová, Jana Kayserová, Eva Froňková, Anna Šedivá

Erschienen in: Journal of Clinical Immunology | Ausgabe 7/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Syndrome diGeorge is associated amongst other clinical signs with various degrees of thymic dysplasia, related immunodeficiency and autoimmune disorders. Helios, a transcription factor from Ikaros family, has been proposed as a marker for thymus derived Tregs. We therefore examined Helios + Tregs in a cohort of patients with genetically proven diGeorge syndrome with typical T cell lymphopenia due to the thymic pathology.

Methods

T cells, FoxP3+ Tregs and Helios + FoxP3+ Tregs were examined in 52 samples from 37 patients. One patient with diGeorge/CHARGE syndrome with total thymic aplasia was also included. Statistical analysis was performed using a linear regression comparison.

Results

Total absolute Tregs were significantly lower in diGeorge patients as compared to controls in all age groups (0–20 years) (p = 0.0016). The difference was more expressed in the first four years of age. Relative Treg numbers expressed as the percentage of Tregs in CD4+ T-cells, however, were not different in patients and controls in all age groups (p = 0.661), neither could we find any significant difference in the percentage of Helios + Tregs between patients and controls (p = 0.238). Helios + Tregs were still present in a patient with diGeorge/CHARGE syndrome with complete athymia 7 years after partially matched unrelated repeated T lymphocytes infusions.

Conclusion

Our findings show that while there was a significant decrease in absolute numbers of Tregs in patients with diGeorge syndrome, the relative percentage of this population did not differ between patients and controls. Low absolute Tregs thus reflected typical T cells lymphopenia in patients. Helios expression was not affected in diGeorge syndrome.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Asano M, Toda M, Sakaguchi N, Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med. 1996;184:387–96.PubMedCrossRef Asano M, Toda M, Sakaguchi N, Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med. 1996;184:387–96.PubMedCrossRef
2.
Zurück zum Zitat Lin X, Chen M, Liu Y, Guo Z, He X, Brand D, et al. Advances in distinguishing natural from induced Foxp3 + regulatory T cells. Int J Clin Exp Pathol. 2013;6:116–23.PubMedPubMedCentral Lin X, Chen M, Liu Y, Guo Z, He X, Brand D, et al. Advances in distinguishing natural from induced Foxp3 + regulatory T cells. Int J Clin Exp Pathol. 2013;6:116–23.PubMedPubMedCentral
3.
Zurück zum Zitat Apostolou I, Verginis P, Kretschmer K, Polansky J, Hühn J, von Boehmer H. Peripherally induced Treg: mode, stability, and role in specific tolerance. J Clin Immunol. 2008;28:619–24.PubMedCrossRef Apostolou I, Verginis P, Kretschmer K, Polansky J, Hühn J, von Boehmer H. Peripherally induced Treg: mode, stability, and role in specific tolerance. J Clin Immunol. 2008;28:619–24.PubMedCrossRef
4.
Zurück zum Zitat Dhamne C, Chung Y, Alousi AM, Cooper LJN, Tran DQ. Peripheral and thymic foxp3 (+) regulatory T cells in search of origin, distinction, and function. Front Immunol. 2013;4:253.PubMedCrossRefPubMedCentral Dhamne C, Chung Y, Alousi AM, Cooper LJN, Tran DQ. Peripheral and thymic foxp3 (+) regulatory T cells in search of origin, distinction, and function. Front Immunol. 2013;4:253.PubMedCrossRefPubMedCentral
5.
Zurück zum Zitat Kelley CM, Ikeda T, Koipally J, Avitahl N, Wu L, Georgopoulos K, et al. Helios, a novel dimerization partner of Ikaros expressed in the earliest hematopoietic progenitors. Curr Biol. 1998;8:508–15.PubMedCrossRef Kelley CM, Ikeda T, Koipally J, Avitahl N, Wu L, Georgopoulos K, et al. Helios, a novel dimerization partner of Ikaros expressed in the earliest hematopoietic progenitors. Curr Biol. 1998;8:508–15.PubMedCrossRef
6.
Zurück zum Zitat Sugimoto N, Oida T, Hirota K, Nakamura K, Nomura T, Uchiyama T, et al. Foxp3-dependent and -independent molecules specific for CD25 + CD4+ natural regulatory T cells revealed by DNA microarray analysis. Int Immunol. 2006;18:1197–209.PubMedCrossRef Sugimoto N, Oida T, Hirota K, Nakamura K, Nomura T, Uchiyama T, et al. Foxp3-dependent and -independent molecules specific for CD25 + CD4+ natural regulatory T cells revealed by DNA microarray analysis. Int Immunol. 2006;18:1197–209.PubMedCrossRef
7.
Zurück zum Zitat Thornton AM, Korty PE, Tran DQ, Wohlfert EA, Murray PE, Belkaid Y, et al. Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J Immunol. 2010;184:3433–41. Thornton AM, Korty PE, Tran DQ, Wohlfert EA, Murray PE, Belkaid Y, et al. Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J Immunol. 2010;184:3433–41.
8.
Zurück zum Zitat DiGeorge AM, Lischner HW, Dacou C, Arey JB (1967) Absence of thymus. Lancet 289. DiGeorge AM, Lischner HW, Dacou C, Arey JB (1967) Absence of thymus. Lancet 289.
9.
Zurück zum Zitat Halford S, Wadey R, Roberts C, Daw S, Whiting J, O’Donnell H, et al. Isolation of a putative transcriptional regulator from the region of 22q11 deleted in DiGeorge syndrome, Shprintzen syndrome and familial congenital heart disease. Hum Mol Genet. 1993;2:2099–107.PubMedCrossRef Halford S, Wadey R, Roberts C, Daw S, Whiting J, O’Donnell H, et al. Isolation of a putative transcriptional regulator from the region of 22q11 deleted in DiGeorge syndrome, Shprintzen syndrome and familial congenital heart disease. Hum Mol Genet. 1993;2:2099–107.PubMedCrossRef
10.
Zurück zum Zitat Jongmans MCJ, Admiraal RJ, van der Donk KP, et al. Charge syndrome: the phenotypic spectrum of mutations in the CHD7 gene. J Med Genet. 2006;43:306–14.PubMedCrossRefPubMedCentral Jongmans MCJ, Admiraal RJ, van der Donk KP, et al. Charge syndrome: the phenotypic spectrum of mutations in the CHD7 gene. J Med Genet. 2006;43:306–14.PubMedCrossRefPubMedCentral
11.
Zurück zum Zitat de Lonlay-Debeney P, Cormier-Daire V, Amiel J, et al. Features of Di George syndrome and Charge association in five patients. J Med Genet. 1997;34:986–9.PubMedCrossRefPubMedCentral de Lonlay-Debeney P, Cormier-Daire V, Amiel J, et al. Features of Di George syndrome and Charge association in five patients. J Med Genet. 1997;34:986–9.PubMedCrossRefPubMedCentral
13.
Zurück zum Zitat Gennery AR, Barge D, O’Sullivan JJ, Flood TJ, Abinun M, Cant AJ. Antibody deficiency and autoimmunity in 22q11.2 deletion syndrome. Arch Dis Child. 2002;86:422–5.PubMedCrossRefPubMedCentral Gennery AR, Barge D, O’Sullivan JJ, Flood TJ, Abinun M, Cant AJ. Antibody deficiency and autoimmunity in 22q11.2 deletion syndrome. Arch Dis Child. 2002;86:422–5.PubMedCrossRefPubMedCentral
14.
Zurück zum Zitat Jawad AF, Prak EL, Boyer J, McDonald-McGinn DM, Zackai E, McDonald K, et al. A prospective study of influenza vaccination and a comparison of immunologic parameters in children and adults with chromosome 22q11.2 deletion syndrome (digeorge syndrome/velocardiofacial syndrome). J Clin Immunol. 2011;31:927–35.PubMedCrossRef Jawad AF, Prak EL, Boyer J, McDonald-McGinn DM, Zackai E, McDonald K, et al. A prospective study of influenza vaccination and a comparison of immunologic parameters in children and adults with chromosome 22q11.2 deletion syndrome (digeorge syndrome/velocardiofacial syndrome). J Clin Immunol. 2011;31:927–35.PubMedCrossRef
15.
Zurück zum Zitat Sullivan KE, Mcdonald-McGinn D, Zackai EH. CD4+ CD25+ T-Cell Production in Healthy Humans and in Patients with Thymic Hypoplasia. Clin Diagn Lab Immunol. 2002;9:1129–31.PubMedPubMedCentral Sullivan KE, Mcdonald-McGinn D, Zackai EH. CD4+ CD25+ T-Cell Production in Healthy Humans and in Patients with Thymic Hypoplasia. Clin Diagn Lab Immunol. 2002;9:1129–31.PubMedPubMedCentral
16.
Zurück zum Zitat Ferrando-Martínez S, Lorente R, Gurbindo D, De José MI, Leal M, Muñoz-Fernández MA, et al. Low thymic output, peripheral homeostasis deregulation, and hastened regulatory T cells differentiation in children with 22q11.2 deletion syndrome. J Pediatr. 2014;164:882–9.PubMedCrossRef Ferrando-Martínez S, Lorente R, Gurbindo D, De José MI, Leal M, Muñoz-Fernández MA, et al. Low thymic output, peripheral homeostasis deregulation, and hastened regulatory T cells differentiation in children with 22q11.2 deletion syndrome. J Pediatr. 2014;164:882–9.PubMedCrossRef
17.
Zurück zum Zitat Janda A, Sedlacek P, Mejstrikova E, et al. Unrelated partially matched lymphocyte infusions in a patient with complete DiGeorge/CHARGE syndrome. Pediatr Transplant. 2007;11:441–7.PubMedCrossRef Janda A, Sedlacek P, Mejstrikova E, et al. Unrelated partially matched lymphocyte infusions in a patient with complete DiGeorge/CHARGE syndrome. Pediatr Transplant. 2007;11:441–7.PubMedCrossRef
18.
Zurück zum Zitat Akimova T, Beier UH, Wang L, Levine MH, Hancock WW. Helios expression is a marker of T cell activation and proliferation. PLoS One. 2011;6:e24226.PubMedCrossRefPubMedCentral Akimova T, Beier UH, Wang L, Levine MH, Hancock WW. Helios expression is a marker of T cell activation and proliferation. PLoS One. 2011;6:e24226.PubMedCrossRefPubMedCentral
19.
Zurück zum Zitat Himmel ME, MacDonald KG, Garcia RV, Steiner TS, Levings MK. Helios and Helios Cells Coexist within the Natural FOXP3+ T Regulatory Cell Subset in Humans. J Immunol. 2013;190:2001–8.PubMedCrossRef Himmel ME, MacDonald KG, Garcia RV, Steiner TS, Levings MK. Helios and Helios Cells Coexist within the Natural FOXP3+ T Regulatory Cell Subset in Humans. J Immunol. 2013;190:2001–8.PubMedCrossRef
20.
Zurück zum Zitat Comans-Bitter WM, de Groot R, van den Beemd R, Neijens HJ, Hop WCJ, Groeneveld K, et al. Immuno phenotyping of blood lymphocytes in childhood - Reference values for lymphocyte subpopulations. J Pediatr. 1997;130:388–93.PubMedCrossRef Comans-Bitter WM, de Groot R, van den Beemd R, Neijens HJ, Hop WCJ, Groeneveld K, et al. Immuno phenotyping of blood lymphocytes in childhood - Reference values for lymphocyte subpopulations. J Pediatr. 1997;130:388–93.PubMedCrossRef
21.
Zurück zum Zitat Pongers-Willemse M. Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes. Leukemia. 1998;12:2006–14.PubMedCrossRef Pongers-Willemse M. Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes. Leukemia. 1998;12:2006–14.PubMedCrossRef
22.
Zurück zum Zitat Weinberg K. Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation. Blood. 2001;97:1458–66.PubMedCrossRef Weinberg K. Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation. Blood. 2001;97:1458–66.PubMedCrossRef
23.
Zurück zum Zitat Van Zelm MC, Szczepanski T, van der Burg M, van Dongen JJM. Replication history of B lymphocytes reveals homeostatic proliferation and extensive antigen-induced B cell expansion. J Exp Med. 2007;204:645–55.PubMedCrossRefPubMedCentral Van Zelm MC, Szczepanski T, van der Burg M, van Dongen JJM. Replication history of B lymphocytes reveals homeostatic proliferation and extensive antigen-induced B cell expansion. J Exp Med. 2007;204:645–55.PubMedCrossRefPubMedCentral
24.
Zurück zum Zitat McLean-Tooke A, Barge D, Spickett GP, Gennery AR. Immunologic defects in 22q11.2 deletion syndrome. J Allergy Clin Immunol. 2008;122:362–7.PubMedCrossRef McLean-Tooke A, Barge D, Spickett GP, Gennery AR. Immunologic defects in 22q11.2 deletion syndrome. J Allergy Clin Immunol. 2008;122:362–7.PubMedCrossRef
25.
Zurück zum Zitat Puck JM. The case for newborn screening for severe combined immunodeficiency and related disorders. Ann N Y Acad Sci. 2011;1246:108–17.PubMedCrossRef Puck JM. The case for newborn screening for severe combined immunodeficiency and related disorders. Ann N Y Acad Sci. 2011;1246:108–17.PubMedCrossRef
26.
Zurück zum Zitat Lingman Framme J, Borte S, von Döbeln U, Hammarström L, Oskarsdóttir S. Retrospective Analysis of TREC Based Newborn Screening Results and Clinical Phenotypes in Infants with the 22q11 Deletion Syndrome. J Clin Immunol. 2014. doi:10.1007/s10875-014-0002-y.PubMed Lingman Framme J, Borte S, von Döbeln U, Hammarström L, Oskarsdóttir S. Retrospective Analysis of TREC Based Newborn Screening Results and Clinical Phenotypes in Infants with the 22q11 Deletion Syndrome. J Clin Immunol. 2014. doi:10.​1007/​s10875-014-0002-y.PubMed
Metadaten
Titel
Helios Expression in T-regulatory Cells in Patients with di George Syndrome
verfasst von
Adam Klocperk
Jarmila Grecová
Kristýna Šišmová
Jana Kayserová
Eva Froňková
Anna Šedivá
Publikationsdatum
01.10.2014
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 7/2014
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-014-0071-y

Weitere Artikel der Ausgabe 7/2014

Journal of Clinical Immunology 7/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.